Equities Analysts Offer Predictions for Allegion Q1 Earnings

Allegion plc (NYSE:ALLE - Free Report) - Investment analysts at Zacks Research raised their Q1 2025 earnings estimates for Allegion in a research report issued to clients and investors on Tuesday, January 14th. Zacks Research analyst R. Department now expects that the scientific and technical instruments company will earn $1.63 per share for the quarter, up from their prior estimate of $1.62. The consensus estimate for Allegion's current full-year earnings is $7.42 per share. Zacks Research also issued estimates for Allegion's Q3 2025 earnings at $2.02 EPS, Q4 2025 earnings at $2.07 EPS, FY2025 earnings at $7.53 EPS, Q1 2026 earnings at $1.60 EPS, Q2 2026 earnings at $1.86 EPS, Q3 2026 earnings at $1.97 EPS, Q4 2026 earnings at $1.93 EPS and FY2026 earnings at $7.36 EPS.

A number of other brokerages have also weighed in on ALLE. Barclays reduced their price target on shares of Allegion from $137.00 to $134.00 and set an "underweight" rating for the company in a research note on Wednesday, January 8th. Morgan Stanley began coverage on Allegion in a research note on Monday, January 6th. They set an "equal weight" rating and a $137.00 price target for the company. StockNews.com downgraded Allegion from a "buy" rating to a "hold" rating in a research note on Tuesday. Mizuho raised their target price on Allegion from $135.00 to $150.00 and gave the company a "neutral" rating in a research note on Thursday, October 17th. Finally, Wells Fargo & Company dropped their price target on shares of Allegion from $152.00 to $140.00 and set an "equal weight" rating on the stock in a research report on Tuesday, January 7th. One research analyst has rated the stock with a sell rating and six have given a hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $140.83.

Allegion Stock Performance

Shares of ALLE stock traded up $1.18 during trading hours on Thursday, reaching $132.11. The stock had a trading volume of 282,482 shares, compared to its average volume of 683,138. The firm has a market capitalization of $11.48 billion, a PE ratio of 20.29, a price-to-earnings-growth ratio of 2.93 and a beta of 1.11. The firm has a 50-day simple moving average of $136.30 and a 200-day simple moving average of $136.17. Allegion has a twelve month low of $113.27 and a twelve month high of $156.10. The company has a debt-to-equity ratio of 1.26, a current ratio of 1.71 and a quick ratio of 1.29.

Allegion (NYSE:ALLE - Get Free Report) last issued its earnings results on Thursday, October 24th. The scientific and technical instruments company reported $2.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.98 by $0.18. The firm had revenue of $967.10 million for the quarter, compared to analysts' expectations of $970.70 million. Allegion had a net margin of 15.36% and a return on equity of 45.64%. Allegion's revenue was up 5.4% on a year-over-year basis. During the same quarter last year, the company posted $1.94 earnings per share.

Allegion Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 31st. Investors of record on Tuesday, December 17th were issued a dividend of $0.48 per share. The ex-dividend date was Tuesday, December 17th. This represents a $1.92 annualized dividend and a dividend yield of 1.45%. Allegion's dividend payout ratio is 29.49%.

Insider Buying and Selling at Allegion

In other Allegion news, CEO John H. Stone purchased 7,500 shares of the business's stock in a transaction dated Tuesday, December 3rd. The shares were acquired at an average price of $140.70 per share, for a total transaction of $1,055,250.00. Following the acquisition, the chief executive officer now owns 120,481 shares of the company's stock, valued at $16,951,676.70. This trade represents a 6.64 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Robert C. Martens sold 8,035 shares of the company's stock in a transaction on Friday, October 25th. The stock was sold at an average price of $144.92, for a total transaction of $1,164,432.20. Following the completion of the sale, the senior vice president now owns 7,104 shares of the company's stock, valued at $1,029,511.68. This represents a 53.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company's stock.

Hedge Funds Weigh In On Allegion

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ALLE. McClarren Financial Advisors Inc. boosted its holdings in shares of Allegion by 61.0% during the 3rd quarter. McClarren Financial Advisors Inc. now owns 190 shares of the scientific and technical instruments company's stock worth $27,000 after buying an additional 72 shares during the period. Brooklyn Investment Group acquired a new stake in shares of Allegion in the third quarter valued at about $28,000. Concord Wealth Partners bought a new position in shares of Allegion in the third quarter worth about $29,000. Cromwell Holdings LLC lifted its position in shares of Allegion by 65.2% during the 3rd quarter. Cromwell Holdings LLC now owns 233 shares of the scientific and technical instruments company's stock worth $34,000 after purchasing an additional 92 shares during the last quarter. Finally, Kimelman & Baird LLC bought a new stake in Allegion during the 2nd quarter valued at approximately $39,000. Institutional investors and hedge funds own 92.21% of the company's stock.

About Allegion

Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door controls and systems and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors, accessories, and other.